 |
|
Intraductal Papillary Mucinous Neoplasm of the Pancreas and Associated Lesions—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We thank Drs Chetty and Serra for their great interest in our article.1 We concluded that patients with intraductal papillary mucinous neoplasms (IPMNs) have a higher risk of developing extrapancreatic neoplasms than those with mucinous cystic neoplasms and pancreatic ductal adenocarcinomas. Our conclusion is not yet definitive owing to the limited number of patients in our study, the rarity of similar reports, and the limitations associated with the retrospective method. However, our conclusions are further supported by similar findings in patients with IPMN.
We have already read the reports, including the report by Drs Chetty and Serra, describing IPMN as one of the extracolonic manifestations of familial adenomatous polyposis or attenuated familial adenomatous polyposis.2-3 Unfortunately, we have not yet experienced any case of a patient with IPMN associated with familial adenomatous polyposis or attenuated familial adenomatous polyposis despite our continuous efforts to detect such an occurrence.
The difference . . . [Full Text of this Article]
AUTHOR INFORMATION
Sun-Whe Kim, MD;
Jin-Young Jang, MD
RELATED ARTICLES
Intraductal Papillary Mucinous Neoplasm of the Pancreas and Associated Lesions
Runjan Chetty and Stefano Serra
Arch Surg. 2006;141(7):716-717.
EXTRACT
| FULL TEXT
High Incidence of Extrapancreatic Neoplasms in Patients With Intraductal Papillary Mucinous Neoplasms
Min-Gew Choi, Sun-Whe Kim, Sung-Sik Han, Jin-Young Jang, and Yong-Hyun Park
Arch Surg. 2006;141(1):51-56.
ABSTRACT
| FULL TEXT
|
